Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial

NCT00273624 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00273624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00273624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial
Lead sponsor
University Hospital Freiburg
Phase
Phase 3
Overall status
Withdrawn
Start date
June 30, 2005
Completion date
December 31, 2009
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

therapy-resistant depression